Cover Image

TFV‐DP adherence interpretations from TDF using an updated 50% methanol and 50% water extraction method for DBS

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Clinical Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dose proportionality and half‐life of tenofovir in hair samples from those with differing adherence to TDF or TAF‐based regimens monitored by directly observed therapy
Published: (2024)

Validating methods used to identify non‐adherence adverse drug events in Canadian administrative health data
by: Maeve E. Wickham, et al.
Published: (2024)

Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases—An update
by: Romane Freppel, et al.
Published: (2026)

Overcoming barriers to adherence through innovative injectable medications: A systematic review of therapeutic options for cardiovascular disease, reported adherence, and perspectives on their use
by: Beata Bajorek, et al.
Published: (2025)

Medication adherence—Everybody's problem but nobody's responsibility?
by: Amy Hai Yan Chan, et al.
Published: (2024)

Development of method using language processing techniques for extracting information on drug–health food product interactions
by: Mari Yoshizaki, et al.
Published: (2024)

Intracellular carbovir‐ and lamivudine‐triphosphate concentrations in PBMC and DBS among children with HIV‐1 receiving ABC/DTG/3TC: Results from IMPAACT 2019
by: S. Schwab, et al.
Published: (2025)

Pan‐European survey on medication adherence management by healthcare professionals
by: Maria Kamusheva, et al.
Published: (2024)

Physicochemical stability of DELSTRIGO®: A combination of three active substances (tenofovir disoproxi fumarate [TDF], lamivudine [3TC] doravirine [DOR]) in the management of occupational in the management of HIV post‐exposure prophylaxis (PEP)
by: E. Hindes, et al.
Published: (2025)

Medication adherence for people with acquired communication disorders: A systematic review
by: Shauna Bell, et al.
Published: (2024)

Medication adherence and hospitalizations in older patients with coronary heart disease in Vietnam
by: Tan Van Nguyen, et al.
Published: (2025)

Estimation of adherence to urate‐lowering therapy in people living with gout using Australia's Pharmaceutical Benefits Scheme and patient‐reported dosing
by: Marcel Schulz, et al.
Published: (2024)

Turkish translation and cultural adaptation of the Ascertaining Barriers to Compliance taxonomy for medication adherence
by: Cansu Goncuoglu, et al.
Published: (2025)

Risk of bias tools for medication adherence research: RoBIAS and RoBOAS
by: Klarissa A. Sinnappah, et al.
Published: (2025)

Evaluation of adherence to abiraterone therapy in prostate cancer patients based on a population pharmacokinetic model
by: Sara Merdita, et al.
Published: (2024)

A systematic review of medication adherence and mortality in chronic disease: Implications for clinical guidelines and policy
by: Jessica Hamuy Blanco, et al.
Published: (2025)

Clinician's attitudes & perspective on chemical adherence testing in hypertension (CATCH): A qualitative interview study
by: Roshan Shahab, et al.
Published: (2026)

Hair analysis of formoterol as a novel tool to assess long‐term inhalation medication adherence: Data from the TRICOLON trial
by: Liz J. A. Cuperus, et al.
Published: (2026)

Medication adherence during the run‐in phase of clinical trials: A systematic review of methodological and reporting rigour
by: Non Davies, et al.
Published: (2025)

Identifying longitudinal medication adherence patterns of antipsychotic treatments: A real‐world cohort study in Catalonia, Spain
by: Marina Fuente‐Moreno, et al.
Published: (2025)

Uptake of DPYD and UGT1A1 testing in Italy and adherence to pharmacogenetic guidelines: A 5‐year perspective from an EQA provider
by: Rossana Roncato, et al.
Published: (2025)

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society
by: Dagan O. Lonsdale, et al.
Published: (2026)

Medication adherence to inflammatory bowel disease medications in Aotearoa New Zealand and correlation with health outcomes: A nationwide database analysis
by: Obreniokibo Ibifubara Amiesimaka, et al.
Published: (2024)

2024 updates to the Québec antiretroviral therapeutic drug monitoring guidelines: Key changes over 10 years
Published: (2024)

The effect of deprescribing interventions on mortality and health outcomes in older people: An updated systematic review and meta‐analysis
by: Hui Wen Quek, et al.
Published: (2024)

Pharmacokinetic parameters of bictegravir in breastmilk of healthy, lactating volunteers without HIV after a single dose of 50 mg (co‐formulated with emtricitabine 200 mg and tenofovir alafenamide 25 mg)
by: L. Van Der Wekken‐Pas, et al.
Published: (2025)

What can pharmacokinetic modelling do for you? Rational design and interpretation of clinical studies
by: Francis Williams Ojara, et al.
Published: (2024)

Exploring the factors associated with difficulties in extracting tablets or capsules from press‐through‐package sheets
by: Masami Tsuchiya, et al.
Published: (2024)

Variability in the prevalence of inappropriate medication use among older adults: A review highlighting the importance of screening methods and database types
by: Romain Léguillon, et al.
Published: (2024)

Assessing the environmental impact of medicines in Italy using data from the Italian Medicines Agency
by: Valentina Giunchi, et al.
Published: (2025)

Plasma 6β‐hydroxycortisol to cortisol ratio as a less invasive cytochrome P450 3A phenotyping method
by: Ryohei Hirano, et al.
Published: (2024)

Appropriateness of oxycodone use for acute pain in surgical and obstetric departments using a clinical data warehouse
by: Fabien Xuereb, et al.
Published: (2025)

Prescription use of acetaminophen among pregnant women in Denmark from 2000 to 2023: A drug utilization study
by: Erika B. Gram, et al.
Published: (2025)

Validity of the Medication Safety Self‐Assessment for Long‐Term Care tool in Australian long‐term care: a RAND appropriateness method study
by: Ramesh Sharma Poudel, et al.
Published: (2025)

Morbimortality consequences of use and misuse of psychoactive medicines in Portugal
by: Ana Carmona Araújo, et al.
Published: (2025)

Formulation breakthroughs driving broader tyrosine kinase use
by: Hans Lennernäs, et al.
Published: (2026)

Analysis of longitudinal patterns and predictors of medicine use in residential aged care using group‐based trajectory modelling: The MEDTRAC‐Polypharmacy longitudinal cohort study
by: Nasir Wabe, et al.
Published: (2024)

Pharmacogenetics in Oncology: A useful tool for individualizing drug therapy
by: Rita Nogueiras‐Álvarez, et al.
Published: (2024)

Evaluation of cytochrome P450 (CYP) induction using RT‐qPCR in exosomes isolated from plasma samples: Method development and qualification
by: Shengjie Xu, et al.
Published: (2026)

Glial modulators as novel therapeutics for comorbid pain and opioid use disorder
by: Elizabeth K. C. Schwartz, et al.
Published: (2024)